General
Preferred name
MELPHALAN FLUFENAMIDE
Synonyms
J-1 ()
Melflufen (hydrochloride) ()
Melphalan flufenamide (hydrochloride) ()
MELPHALAN FLUFENAMIDE HYDROCHLORIDE ()
Pepaxto ()
Melflufen ()
Melflufen hydrochloride ()
J1 hydrochloride ()
CK-1535 ()
CK 1535 ()
Pepaxti ()
J-1 HYDROCHLORIDE ()
PRODRUG J-1 ()
J-1 (PRODRUG) ()
J1 ()
J1 (PRODRUG) ()
PRODRUG J 1 ()
J 1 (PRODRUG) ()
PRODRUG J1 ()
Melfalan flufenamida ()
P&D ID
PD151396
CAS
380449-51-4
380449-54-7
Tags
available
prodrug
drug
Approved by
FDA
EMA
First approval
2021
Drug indication
Multiple myeloma
Plasma cell myeloma
Ovarian cancer
Drug Status
approved
withdrawn
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Melphalan flufenamide is a peptide-conjugated prodrug of the cytotoxic DNA alkylating drug . It is highly lipophilic and is rapidly transported into cells where it is quickly hydrolysed by aminopeptidases that are overexpressed by some cancer cells. Melphalan flufenamide is being evaluated as a treatment for multiple myeloma .
The IUPAC Condensed peptide sequence for melphalan flufenamide is H-Phe(Unk)-Phe(4-F)-OEt. (GtoPdb)
The IUPAC Condensed peptide sequence for melphalan flufenamide is H-Phe(Unk)-Phe(4-F)-OEt. (GtoPdb)
DESCRIPTION
Melphalan flufenamide, is a melphalan prodrug in which the alkylating agent melphalan is bound to flufenamide, alkylates DNA at the N7 position of guanine residues and induces DNA intra- and inter-strand cross-linkages.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
13
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
27
Molecular Weight
497.16
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
13
Ring Count
2
Aromatic Ring Count
2
cLogP
3.27
TPSA
84.66
Fraction CSP3
0.42
Chiral centers
2.0
Largest ring
6.0
QED
0.33
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Apoptosis
DNA alkylator/crosslinker
Pathway
Cell Cycle/DNA Damage
Solubility
Soluble in DMSO
Source data

